BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37577790)

  • 41. Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease.
    Michaux M; Chan JM; Bergmann L; Chaves LF; Klinkenberg B; Jacobson K
    World J Gastroenterol; 2023 Jun; 29(23):3688-3702. PubMed ID: 37398882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
    Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
    Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
    Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
    Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
    Fujiya M; Kawaguchi T; Arai S; Isogawa N; Hiro S; Matsumoto F; Yamaguchi S; Yoshii N; Nakamura M; Matsuoka K
    Dig Dis Sci; 2022 Nov; 67(11):5195-5205. PubMed ID: 35150345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
    Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review and meta-analysis of prospective studies on obesity and risk of inflammatory bowel disease.
    Milajerdi A; Abbasi F; Esmaillzadeh A
    Nutr Rev; 2022 Feb; 80(3):479-487. PubMed ID: 34157115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Tsai L; Nguyen NH; Ma C; Prokop LJ; Sandborn WJ; Singh S
    Dig Dis Sci; 2022 Jun; 67(6):2451-2461. PubMed ID: 34379220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group.
    Russel MG; Dorant E; Brummer RJ; van de Kruijs MA; Muris JW; Bergers JM; Goedhard J; Stockbrügger RW
    Gastroenterology; 1997 Aug; 113(2):377-82. PubMed ID: 9247453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
    Halpin SJ; Ford AC
    Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps.
    Wolf T; Lewis A; Beaugerie L; Svrcek M; Kirchgesner J;
    Aliment Pharmacol Ther; 2023 Jun; 57(12):1445-1452. PubMed ID: 37002640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Pinto-Sanchez MI; Seiler CL; Santesso N; Alaedini A; Semrad C; Lee AR; Bercik P; Lebwohl B; Leffler DA; Kelly CP; Moayyedi P; Green PH; Verdu EF
    Gastroenterology; 2020 Sep; 159(3):884-903.e31. PubMed ID: 32416141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
    Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
    Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.
    Koutroubakis IE; Regueiro M; Schoen RE; Ramos-Rivers C; Hashash JG; Schwartz M; Swoger J; Barrie A; Baidoo L; Dunn MA; Hartman D; Binion DG
    Inflamm Bowel Dis; 2016 Jan; 22(1):100-5. PubMed ID: 26355468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory bowel disease and the risk of intracerebral hemorrhage: A Mendelian randomization study and meta-analysis.
    Song Y; Zou X; Zeng Y; Zhang L; Mao X
    Immun Inflamm Dis; 2023 Oct; 11(10):e1048. PubMed ID: 37904677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
    Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
    [No Abstract]   [Full Text] [Related]  

  • 60. Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease.
    Lu MJ; Qiu XY; Mao XQ; Li XT; Zhang HJ
    Aliment Pharmacol Ther; 2018 Feb; 47(3):318-331. PubMed ID: 29205426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.